1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Hernando V, Suárez L, Gutiérrez G, López JC, Navarro-Soler R, Cabello A, Sanz J, Suarez-García I, Fernández MT, Losa JE, Pérez JL, Ramos-Ruperto L, Pérez-Elías MJ, Aayuni WBCE, Cuesta M, González G, Izquierdo A, Viloria L, López I, Martínez E, Castrillejo D, Jaume Amengual MG, Belmonte MA, Arraiza A, de la Torre J, Miqueleiz E, Marcos H, Ruiz-Algueró M, Villegas T, Simón L, Diaz A.

    Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.07.006]

  • Berna-Rico E, Chamorro-Tojeiro S, Pérez-González A, Pérez-García B.

    Superinfected scabies.

    MEDICINA CLINICA . : .

    [doi:10.1016/j.medcli.2023.06.048]

  • Norman FF, Gonzalez-Sanz M, Gullón-Peña B, Chamorro-Tojeiro S, Rosas M, Crespillo-Andujar C, Monge-Maillo B, Comeche B, Corbacho-Loarte MD, Arcas C, Peña I, Tenorio MC, Lopez-Vélez R, Pérez-Molina JA.

    Haemoglobinopathies in mobile populations from sub-Saharan Africa

    JOURNAL OF TRAVEL MEDICINE . : .

    [doi:10.1093/jtm/taad115]

  • Moreno S, Rivero A, Ventayol P, Falcó V, Torralba M, Schroeder M, Neches V, Vallejo-Aparicio LA, Mackenzie I, Turner M, Harrison C.

    Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.

    Infectious diseases and therapy . 12(8): 2039-2055.

    [doi:10.1007/s40121-023-00840-y]

  • Palacios R, Gómez-Ayerbe C, Casado JL, Tejerina F, Montes ML, Castaño M, Ocampo A, Rial D, Ribera E, Galindo MJ, Hidalgo C, Fariñas C, Montero M, Payeras T, Fanjul F, de la Torre J, Santos J.

    Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119

    HIV MEDICINE . 24(8): 933-937.

    [doi:10.1111/hiv.13489]

  • Pérez-Molina JA, Crespillo-Andújar C, Trigo E, Chamorro S, Arsuaga M, Olavarrieta L, Navia B, Martín O, Monge-Maillo B, Norman FF, Lanza VF, Serrano-Villar S.

    Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study).

    PLOS NEGLECTED TROPICAL DISEASES . 17(7): .

    [doi:10.1371/journal.pntd.0011490]

  • Barbero Allende JM, Gómez-Junyent J, Sorlí Redó L, Rodríguez-Pardo D, Murillo Rubio Ó, Fernández Sampedro M, Escudero-Sánchez R, García Gutiérrez M, Portillo ME, Sancho I, Rico Nieto A, Guio Carrión L, Soriano A, Morata Ruiz L.

    Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.07.002]

  • Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, Cabello-Ubeda A, Sendagorta E, Kurz A, Perez Molina JA, de Benito A, Hov JR, Fernandez-Lopez L, Muriel A, Del Campo R, Moreno S, Trøseid M, Seifert J, Ferrer M.

    Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.

    NATURE MEDICINE . 29(7): 1738-1749. Number of citations: 2

    [doi:10.1038/s41591-023-02407-3]

  • Rosas Cancio-Suárez M, Díaz-Álvarez J, Ron R, Martínez-Sanz J, Serrano-Villar S, Moreno S, Sánchez-Conde M.

    From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications.

    PATHOGENS . 12(7): .

    [doi:10.3390/pathogens12070924]

  • Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J.

    Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78(7): 1658-1666.

    [doi:10.1093/jac/dkad147]

  • Ruiz-Cáceres I, Hermida Romero T, Guerra Merino I, Portu Zapirain J, Pérez-Mies B, Sánchez-Conde M, Riaño MA, Rubio R, Fortés Alen J, Vidal González Á, Salas Antón C, Múñez E, Sánchez Sánchez R, Corona-Mata D, Aldecoa Ansorregui I, Miró JM, Beloqui Pérez de Obanos R, Ibero C, Gómez-Román J, Fariñas MC, Tabuyo Bello T, de Alava E, Cisneros JM, Matías-Guiu X, Rivero A.

    Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections.

    Frontiers In Medicine . 10: 1151843-1151843.

    [doi:10.3389/fmed.2023.1151843]

  • Serrano-Villar, Sergio, Ferrer, Manuel.

    How the microbiome can help detect precancerous lesions and prevent anal cancer

    NATURE MEDICINE . 29(7): 1619-1620.

    [doi:10.1038/s41591-023-02421-5]

  • Maia C, Conceição C, Pereira A, Rocha R, Ortuño M, Muñoz C, Jumakanova Z, Pérez-Cutillas P, Özbel Y, Töz S, Baneth G, Monge-Maillo B, Gasimov E, Van der Stede Y, Torres G, Gossner CM, Berriatua E.

    The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005-2020

    PLOS NEGLECTED TROPICAL DISEASES . 17(7): . Number of citations: 2

    [doi:10.1371/journal.pntd.0011497]

  • Candel FJ, Barreiro P, Salavert M, Cabello A, Fernández-Ruiz M, Pérez-Segura P, San Román J, Berenguer J, Córdoba R, Delgado R, España PP, Gómez-Centurión IA, González Del Castillo JM, Heili SB, Martínez-Peromingo FJ, Menéndez R, Moreno S, Pablos JL, Pasquau J, Piñana JL, On Behalf Of The Modus Investigators Adenda.

    Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    VIRUSES-BASEL . 15(7): . Number of citations: 1

    [doi:10.3390/v15071449]

  • González-Sanz M, Berzosa P, Norman FF.

    Updates on Malaria Epidemiology and Prevention Strategies

    CURRENT INFECTIOUS DISEASE REPORTS . 25(7): 131-139. Number of citations: 1

    [doi:10.1007/s11908-023-00805-9]

  • Puerta-Alcalde P, Monzó-Gallo P, Aguilar-Guisado M, Ramos JC, Laporte-Amargós J, Machado M, Martin-Davila P, Franch-Sarto M, Sánchez-Romero I, Badiola J, Gómez L, Ruiz-Camps I, Yáñez L, Vázquez L, Chumbita M, Marco F, Soriano A, González P, Fernández-Cruz A, Batlle M, Fortún J, Guinea J, Gudiol C, García J, Ruiz Pérez de Pipaón M, Alastruey-Izquierdo A, Garcia-Vidal C.

    Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    JOURNAL OF INFECTION . 87(1): 46-53. Number of citations: 2

    [doi:10.1016/j.jinf.2023.05.005]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Gómez-Maldonado S, Muedra-Sánchez M, Del Pino J, Mirabella IG, Martín-Colmenarejo S, Haemmerle J, Fernández-Escribano M, Vallejo A.

    mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection

    Frontiers in immunology . 14: 1127379-1127379.

    [doi:10.3389/fimmu.2023.1127379]

  • García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

    HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health . 11: 1136988-1136988.

    [doi:10.3389/fpubh.2023.1136988]